| Issue Type | XXXX |
|---|---|
| Country | Japan |
| Industry | XXXX |
| Region | XXXX |
| Maturity Date | 2027-12-03 |
| Par Value | 100000000 |
| Callable | XXXX |
| Next Call Date | XXXX |
| Call Type | XXXX |
| Call Price (%) | XXXX |
| Series | XXXX |
| Class | XXXX |
| Maturity Structure | XXXX |
| Amount Outstanding (mil) | 20000.00 |
| Coupon | 0.419 |
|---|---|
| Coupon Type | XXXX |
| Coupon Frequency | XXXX |
| First Coupon Date | XXXX |
| Last Coupon Date | XXXX |
| Sinking Fund | XXXX |
|---|---|
| Security | XXXX |
| Subordination | XXXX |
| Debt Type | XXXX |
| Issue Date | XXXX |
|---|---|
| Dated Date | XXXX |
| Issue Size (mil) | 20000 |
| Min. Piece | XXXX |
| Min. Increment | XXXX |
This Astellas Pharma Inc. corporate bond has a X.X % fixed rate coupon paid on a XXXX basis. It was issued on MAR 12, 2000 with an issue size of XXX million JPY and matures on DEC 9, 2000 with a last coupon date of FEB 28, 2020. |
Astellas Pharma Inc., founded in 2005 and headquartered in Tokyo, Japan, is a leading global pharmaceutical company dedicated to improving the health of patients through innovative medicines. The company specializes in a range of therapeutic areas, including urology, oncology, immunology, and neuroscience, with key products such as Xtandi, a treatment for prostate cancer, and Betanis for overactive bladder.